← Open Payments lookup

ABRAM NUNN: Open Payments

NPI 1952730020 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,683 in 76 payments from 11 companies in 2025. Trend: 2023 $662 · 2024 $1,165 · 2025 $1,683

Food & beverage: $1,572Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$300
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$274
Alkermes, Inc.13$268
Neurocrine BioSciences, Inc.9$238
Teva Pharmaceuticals USA, Inc.9$213
Axsome Therapeutics, Inc.4$104
E.R. Squibb & Sons, L.L.C.5$91
Janssen Pharmaceuticals, Inc3$91
Lundbeck LLC2$64
Vanda Pharmaceuticals Inc.1$23

Products named: CAPLYTA, REXULTI, ARISTADA, INGREZZA, Auvelity, UZEDY, ABILIFY ASIMTUFII, COBENFY.

Industry payments across CA — which companies pay providers there.